Bibliography
- PAPATSORIS AG, LIOLITSA D, DELIVELIOTIS C: Manipulation of the nerve growth factor network in prostate cancer. Expert Opin. Investig. Drugs (2007) 16(3):303-309.
- CHAO MV, RAJAGOPAL R, LEE FS: Neurotrophin signalling in health and disease. Clin. Sci. (2006) 110:167-173.
- ALLEN SJ, DAWBARN D: Clinical relevance of the neurotrophins and their receptors. Clin. Sci. (2006) 110:175-191.
- HEESE K, LOW JW, INOUE N: Nerve growth factor, neural stem cells and Alzheimer's disease. Neurosignals (2006-2007) 15:1-12.
- LLEO A, GREENBERG SM, GROWDON JH: Current pharmacotherapy for Alzheimer's disease. Ann. Rev. Med. (2006) 57:513-533.
- COUNTS SE, MUFSON EJ: The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J. Neuropathol. Exp. Neurol. (2005) 64:263-272.
- LAMBIASE A, PAGANI L, DI FAUSTO V et al.: Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res. (2007) 1127:45-51.
- TUSZYNSKI MH, THAL L, PAY M et al.: A Phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. (2005) 11:551-555.
- JEANNETEAU F, CHAO MV: Promoting neurotrophic effects by GPCR ligands. Novartis Foundation Symposia (2006) 276:181-189.
- DAWBARN D, FAHEY M, WATSON J et al.: NGF receptor TrkAd5: therapeutic agent and drug design target. Biochem. Soc. Trans. (2006) 34:587-590.